• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atopic dermatitis, dupilumab and cancers: a case series.

作者信息

Siliquini N, Giura M T, Viola R, Ribero S, Panzone M, Dapavo P, Fierro M T, Ortoncelli M, Quaglino P

机构信息

Dermatology Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e651-e652. doi: 10.1111/jdv.17264. Epub 2021 Jun 11.

DOI:10.1111/jdv.17264
PMID:33797094
Abstract
摘要

相似文献

1
Atopic dermatitis, dupilumab and cancers: a case series.特应性皮炎、度普利尤单抗与癌症：病例系列
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e651-e652. doi: 10.1111/jdv.17264. Epub 2021 Jun 11.
2
Dupilumab for atopic dermatitis.
Pediatr Dermatol. 2021 Nov;38(6):1559-1560. doi: 10.1111/pde.14872.
3
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response.度普利尤单抗治疗特应性皮炎：治疗结果和起效时间的预测因素
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e896-e898. doi: 10.1111/jdv.17541. Epub 2021 Aug 16.
4
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.度普利尤单抗治疗成人特应性皮炎钱币状湿疹表型的有效性。
Dermatol Ther. 2020 May;33(3):e13290. doi: 10.1111/dth.13290. Epub 2020 Mar 11.
5
Dupilumab ocular surface disease occurs predominantly in patients receiving dupilumab for atopic dermatitis: A multi-institution retrospective chart review.度普利尤单抗所致眼表疾病主要发生在接受度普利尤单抗治疗特应性皮炎的患者中：一项多机构回顾性病历审查。
J Am Acad Dermatol. 2021 Sep;85(3):735-736. doi: 10.1016/j.jaad.2019.07.031. Epub 2019 Jul 17.
6
Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.重度特应性皮炎：度普利尤单抗不仅更安全，而且更有效。
Allergol Immunopathol (Madr). 2020 Nov-Dec;48(6):792-797. doi: 10.1016/j.aller.2019.12.005. Epub 2020 Apr 2.
7
Success of dupilumab as a monotherapy in an adult patient affected by severe uncontrolled asthma and atopic dermatitis.度普利尤单抗单药治疗一名患有严重难治性哮喘和特应性皮炎的成年患者取得成功。
Dermatol Ther. 2021 Jan;34(1):e14596. doi: 10.1111/dth.14596. Epub 2020 Dec 25.
8
Dupilumab-associated hypereosinophilia in patients treated for moderate-to-severe atopic dermatitis.接受度普利尤单抗治疗的中度至重度特应性皮炎患者中与度普利尤单抗相关的嗜酸性粒细胞增多症。
J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e394-e396. doi: 10.1111/jdv.17177. Epub 2021 Mar 5.
9
Severe eczema in Wiskott-Aldrich syndrome-related disorder successfully treated with dupilumab.威斯科特-奥尔德里奇综合征相关疾病导致的严重湿疹经度普利尤单抗治疗后得到成功缓解。
Pediatr Dermatol. 2024 Jan-Feb;41(1):143-144. doi: 10.1111/pde.15397. Epub 2023 Jul 19.
10
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.度普利尤单抗治疗成人中重度特应性皮炎多中心真实世界经验的48周更新情况
J Dermatolog Treat. 2022 Mar;33(2):1146-1149. doi: 10.1080/09546634.2020.1773379. Epub 2020 Jul 3.

引用本文的文献

1
Tumors in the setting of dupilumab use: A review of the literature.度普利尤单抗使用情况下的肿瘤：文献综述
World Allergy Organ J. 2024 Dec 11;18(1):101006. doi: 10.1016/j.waojou.2024.101006. eCollection 2025 Jan.
2
Efficacy and safety of dupilumab in a patient with metastatic clear cell renal cell carcinoma.度普利尤单抗治疗转移性透明细胞肾细胞癌患者的疗效和安全性。
J Int Med Res. 2024 Nov;52(11):3000605241297551. doi: 10.1177/03000605241297551.
3
Atopic Dermatitis Onset in a Melanoma Patient Under Pembrolizumab Therapy: A Case of Successful Treatment with Dupilumab.
帕博利珠单抗治疗的黑色素瘤患者发生特应性皮炎：度普利尤单抗成功治疗一例
Indian J Dermatol. 2024 May-Jun;69(3):268-269. doi: 10.4103/ijd.ijd_123_23. Epub 2024 Jun 26.
4
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.合并症和特殊人群的中重度特应性皮炎患者的生物制剂和小分子治疗：意大利视角
Dermatol Reports. 2023 Sep 13;16(2):9839. doi: 10.4081/dr.2023.9839. eCollection 2024 Jun 14.
5
The dichotomy of regulatory B cells in cancer versus allergic disease.调节性 B 细胞在癌症与过敏性疾病中的双重作用。
Mol Carcinog. 2024 Jan;63(1):11-21. doi: 10.1002/mc.23633. Epub 2023 Sep 15.
6
Real-Life Safety and Effectiveness of Dupilumab in Patients with Concomitant Malignancies: a Case Series.度普利尤单抗在合并恶性肿瘤患者中的真实世界安全性和有效性：病例系列
Dermatol Pract Concept. 2023 Jul 1;13(3):e2023143. doi: 10.5826/dpc.1303a143.
7
Atopic Dermatitis with Multiple Comorbidities Treated with Dupilumab. A Case Report and Review of the Literature Regarding the Safety of Dupilumab.使用度普利尤单抗治疗的伴有多种合并症的特应性皮炎。一例病例报告及关于度普利尤单抗安全性的文献综述
Life (Basel). 2022 Oct 21;12(10):1670. doi: 10.3390/life12101670.
8
Overview of use, efficacy, and safety of dupilumab in complex patients: a retrospective, case-series study from a large, urban academic center.在复杂患者中使用、疗效和安全性概述：来自大型城市学术中心的回顾性、病例系列研究。
Arch Dermatol Res. 2023 Aug;315(6):1777-1781. doi: 10.1007/s00403-022-02362-y. Epub 2022 Jun 18.